Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P220031/S001

LimiFlex Dynamic Sagittal Tether

Empirical Spine, Inc. · Decision date Apr 8, 2026

FDA DECISIONP220031/S001

What did the FDA approve?

FDA records P220031/S001 as a supplement to PMA P220031, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Apr 8, 2026.

FDA approval order statement

approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P220031
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Orthopedic
Decision date
Apr 8, 2026
FDA change category
Postapproval Study Protocol

FDA source record

Regulatory record facts

Identifier
P220031/S001
Regulatory pathway
PMA supplement
Product code
SGK
Decision code
APPR
Decision date
Apr 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, spinous process tension band implant.

Product code
SGK
FDA device class
3

For the original device and its historical approval scope, see PMA P220031. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P220031 · Original PMA

    LimiFlex Dynamic Sagittal Tether

  2. P220031/S001 received

    Application receipt date recorded by FDA.

  3. P220031/S001 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P220031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220031

Product / regulatory recordCompanyPathwayDecision dateSource
Empirical Spine, Inc.PMA approvalFeb 12, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Empirical Spine, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
18655 Madrone Pkwy., Suite 180, Morgan Hill, CA, 95037

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records